(Date:7/25/2008)...stCall/ -- Thoratec,Corporation (Nasdaq: THOR ) a...ry support therapies to save, support and restore ...t its operating results for the second,quarter and... 31., The company will hold a conference call to ...ties to all interested parties at 1:30 p.m.,Pacif...
(Date:7/25/2008)...or obese is not only a personal issue that affects...at impacts other people in society. A new study in...at the extra Medicare cost associated with overwei...cial burden on tax payers, costing up to hundreds ...edicare population. , The article,s findings sh...
(Date:7/25/2008)...y.com announces the,availability of Trade Alerts o...ll of the daily trading notes for free by visiting...ts include: DUSA Pharmaceuticals Inc. (Nasdaq: DU...BRK ), NovaMed Inc. (Nasdaq:,NOVA), Adolor Corp. (...and,Abaxis Inc. (Nasdaq: ABAX )., Join investor ...
(Date:7/25/2008)...ense and Federal Agencies in, the execution of Op...s a, four-day, multi-agency collaborative traini...cal agencies with large and complex incident respo...d-hoc, secure mobile communications infrastructu... Va., July 25 /PRNewswire/ -- Dataline LLC is plea...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ ...nt of Justice:, Chairman Conyers, Ranking Member ... the opportunity to testify today., Since I appea... have,become even better acquainted with the talen...artment and with the work they do, and I have come...
(Date:7/23/2008)... SEATTLE, July 23 /- D...ed that it expects the Independent Data,Monitoring...terim analysis,of overall survival relating to the...ate AdenoCarcinoma Treatment, also known as D9902B...OVENGE is the Company,s investigational,active cel...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin M...oring solutions for more than 20 years, has entere... technology to measure,regional oxygen saturation....gy is the continuous monitoring of the regional bl..., Early testing data and outcomes from an ongoing...
(Date:7/22/2008)... - State-of-the-Art PET Study Confirms Tyrima Ex... Properties - - Results Support Initiat...GLE PARK, N.C., July 22 /- CeNeRx Bio...and commercializing innovative,treatments for dise...d,plans to advance its lead candidate Tyrima(TM) i...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Bottom trawling impacts clearly visible from space 2221 1Bottom trawling impacts clearly visible from space 2221 2Bottom trawling impacts clearly visible from space 2221 3Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 1Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 2DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 1DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 2Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 1Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 2Curved shafts and tips with 6 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches.
Curved shafts and tips with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in closed position with polished finish. Overall length 4.3 inches.
5 mm tying platform. Round knurled handle with dull finish. Curved shafts. Overall length 3.9 inches.
Slightly curved 10 mm jaws and serrated cross action handle with polished finish. Overall length 4.6 inches.
Medicine Products: